Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRT - Inflammation Imaging Study
NCT02576067Phase 3Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Dec 2015
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in atherosclerotic cardiovascular disease (ASCVD) and vasculitis comparing Low dose methotrexate with Placebo (2 arms). Primary endpoint: Change in Arterial Inflammation at 8 months. Started Dec 2015; status: completed.
02
Drugs
methotrexate
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)vasculitis
Beyond the preview
Go deeper on NCT02576067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576067.